======= FRMPD4 ======= == Gene Information == * **Official Symbol**: FRMPD4 * **Official Name**: FERM and PDZ domain containing 4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9758|9758]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q14CM0|Q14CM0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FRMPD4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FRMPD4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300838|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a multi-domain (WW, PDZ, FERM) containing protein. Through its interaction with other proteins (such as PSD-95), it functions as a positive regulator of dendritic spine morphogenesis and density, and is required for the maintenance of excitatory synaptic transmission. [provided by RefSeq, Jan 2010]. COMPLETENESS: complete on the 3' end. * **UniProt Summary**: Positive regulator of dendritic spine morphogenesis and density. Required for the maintenance of excitatory synaptic transmission. Binds phosphatidylinositol 4,5-bisphosphate. {ECO:0000269|PubMed:19118189}. |FERM M| |PDZ| |positive regulation of synapse structural plasticity| |regulation of synapse structural plasticity| |postsynaptic actin cytoskeleton organization| |postsynaptic cytoskeleton organization| |phosphatidylinositol-4,5-bisphosphate binding| |postsynapse organization| |dendritic spine| |regulation of synapse organization| |regulation of synapse structure or activity| |postsynaptic density| |synapse organization| |glutamatergic synapse| |cytoskeleton| |actin cytoskeleton organization| |actin filament-based process| |protein-containing complex| |cytoskeleton organization| |positive regulation of cellular component organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|-2.43| |[[:results:exp406|Thalidomide 20μM R07 exp406]]|-1.75| |[[:results:exp180|Dynasore 10μM R04 exp180]]|-1.71| |[[:results:exp493|IL-3 9ng/ml R08 exp493]]|1.95| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|2.31| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/694 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/26| |bone|0/26| |breast|0/30| |central nervous system|0/49| |cervix|0/4| |colorectal|0/17| |esophagus|0/11| |fibroblast|0/1| |gastric|0/14| |kidney|0/18| |liver|0/19| |lung|0/72| |lymphocyte|0/16| |ovary|0/25| |pancreas|0/22| |peripheral nervous system|0/15| |plasma cell|0/12| |prostate|0/1| |skin|0/20| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/28| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17004 * **Expression level (log2 read counts)**: -1.19 {{:chemogenomics:nalm6 dist.png?nolink |}}